Anti-cancer Drug Development: Computational Strategies to Identify and Target Proteins Involved in Cancer Metabolism

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|4|532-577

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.4, 2013-02, pp. : 532-577

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Cancer Drug Discovery and Development Summit

By Blakey David C  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1577-1582

Informa Healthcare

Access to resources Recommend Favorite

G-quadruplex DNA: a potential target for anti-cancer drug design

By Han H.   Hurley L.H.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 4, 2000-04 ,pp. : 136-142

Elsevier

Access to resources Recommend Favorite

Advances of AKT Pathway in Human Oncogenesis and as a Target for Anti-Cancer Drug Discovery

By  

Current Cancer Drug Targets, Vol. 8, Iss. 1, 2008-02 ,pp. : 2-6

Bentham Science Publishers

Access to resources Recommend Favorite

An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs

By Phan Viet Hong   Tan Cindy   Rittau Anneliese   Xu Hongmei   McLachlan Andrew J   Clarke Stephen J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1395-1410

Informa Healthcare

Access to resources Recommend Favorite

The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development

By  

Current Cancer Drug Targets, Vol. 4, Iss. 3, 2004-05 ,pp. : 235-256

Bentham Science Publishers

Access to resources Recommend Favorite